ID   TIAM2_HUMAN             Reviewed;        1701 AA.
AC   Q8IVF5; B2RP56; C9JZV2; Q6NXN9; Q6ZUP9; Q9UFG6; Q9UKV9; Q9UKW0;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 4.
DT   10-MAY-2017, entry version 121.
DE   RecName: Full=T-lymphoma invasion and metastasis-inducing protein 2;
DE            Short=TIAM-2;
DE   AltName: Full=SIF and TIAM1-like exchange factor;
GN   Name=TIAM2; Synonyms=KIAA2016, STEF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE [MRNA] OF
RP   634-1701 (ISOFORM 5), FUNCTION, TISSUE SPECIFICITY, AND VARIANT
RP   PRO-1089.
RX   PubMed=10512681; DOI=10.1006/geno.1999.5936;
RA   Chiu C.-Y., Leng S., Martin K.A., Kim E., Gorman S., Duhl D.M.;
RT   "Cloning and characterization of T-cell lymphoma invasion and
RT   metastasis 2 (TIAM2), a novel guanine nucleotide exchange factor
RT   related to TIAM1.";
RL   Genomics 61:66-73(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PRO-1089.
RC   TISSUE=Brain;
RA   Nagase T., Kikuno R., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT
RP   PRO-1089.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   PRO-1089.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 446-1701 (ISOFORM 2), AND
RP   VARIANT PRO-1089.
RC   TISSUE=Fetal brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- FUNCTION: Modulates the activity of RHO-like proteins and connects
CC       extracellular signals to cytoskeletal activities. Acts as a GDP-
CC       dissociation stimulator protein that stimulates the GDP-GTP
CC       exchange activity of RHO-like GTPases and activates them. Mediates
CC       extracellular laminin signals to activate Rac1, contributing to
CC       neurite growth. Involved in lamellipodial formation and
CC       advancement of the growth cone of embryonic hippocampal neurons.
CC       Promotes migration of neurons in the cerebral cortex. When
CC       overexpressed, induces membrane ruffling accompanied by the
CC       accumulation of actin filaments along the altered plasma membrane
CC       (By similarity). Activates specifically RAC1, but not CDC42 and
CC       RHOA. {ECO:0000250, ECO:0000269|PubMed:10512681}.
CC   -!- SUBUNIT: Interacts with MAP1A, MAP1B, PARP1 and YWHAE. Interacts
CC       with CD44, PARD3 and MAPK8IP2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell projection,
CC       lamellipodium {ECO:0000250}. Cell projection, filopodium
CC       {ECO:0000250}. Cell projection, growth cone. Note=Localizes to the
CC       plasma membrane in neurites. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q8IVF5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IVF5-2; Sequence=VSP_030975;
CC       Name=3; Synonyms=Short;
CC         IsoId=Q8IVF5-3; Sequence=VSP_030971;
CC       Name=4;
CC         IsoId=Q8IVF5-4; Sequence=VSP_030972;
CC       Name=5; Synonyms=Long;
CC         IsoId=Q8IVF5-5; Sequence=VSP_030974;
CC   -!- TISSUE SPECIFICITY: Expressed in the occipital, frontal and
CC       temporal lobes, cerebellum, putamen and testis.
CC       {ECO:0000269|PubMed:10512681}.
CC   -!- DOMAIN: The PH 1 domain and amino acids 621-782 (a region called
CC       TSS; otherwise known as CC-Ex) are necessary for membrane
CC       localization. The PH 1 and TSS domains are necessary for Rac1
CC       activity. The PH 2 domain is engaged in the enhancement of the
CC       catalytic activity of the adjacent DH domain. The PH 1, TSS and DH
CC       domains are necessary to induce neurite-like structure (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated on serine and threonine residues.
CC       Phosphorylated on Thr-1648 by Rho-kinase. Its phosphorylation by
CC       Rho-kinase inhibits its guanine nucleotide exchange activity, its
CC       interaction with MAP1A, MAP1B, PARP1 and YWHAE and reduces its
CC       ability to promote neurite growth (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the TIAM family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF05900.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC23112.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAC86170.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF120323; AAF05900.1; ALT_INIT; mRNA.
DR   EMBL; AF120324; AAF05901.1; -; mRNA.
DR   EMBL; AB095936; BAC23112.2; ALT_INIT; mRNA.
DR   EMBL; AL122086; CAB59259.2; -; mRNA.
DR   EMBL; AL139101; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596202; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47693.1; -; Genomic_DNA.
DR   EMBL; BC066979; AAH66979.1; -; mRNA.
DR   EMBL; BC137275; AAI37276.1; -; mRNA.
DR   EMBL; AK125459; BAC86170.1; ALT_INIT; mRNA.
DR   CCDS; CCDS34558.1; -. [Q8IVF5-1]
DR   CCDS; CCDS34559.1; -. [Q8IVF5-3]
DR   RefSeq; NP_001010927.1; NM_001010927.2.
DR   RefSeq; NP_036586.2; NM_012454.3.
DR   UniGene; Hs.586279; -.
DR   ProteinModelPortal; Q8IVF5; -.
DR   SMR; Q8IVF5; -.
DR   BioGrid; 117621; 9.
DR   IntAct; Q8IVF5; 6.
DR   MINT; MINT-6776496; -.
DR   STRING; 9606.ENSP00000327315; -.
DR   iPTMnet; Q8IVF5; -.
DR   PhosphoSitePlus; Q8IVF5; -.
DR   BioMuta; TIAM2; -.
DR   DMDM; 296453025; -.
DR   MaxQB; Q8IVF5; -.
DR   PaxDb; Q8IVF5; -.
DR   PeptideAtlas; Q8IVF5; -.
DR   PRIDE; Q8IVF5; -.
DR   Ensembl; ENST00000275246; ENSP00000275246; ENSG00000146426. [Q8IVF5-3]
DR   Ensembl; ENST00000318981; ENSP00000327315; ENSG00000146426. [Q8IVF5-1]
DR   Ensembl; ENST00000360366; ENSP00000353528; ENSG00000146426. [Q8IVF5-5]
DR   Ensembl; ENST00000456877; ENSP00000407183; ENSG00000146426. [Q8IVF5-4]
DR   Ensembl; ENST00000461783; ENSP00000437188; ENSG00000146426. [Q8IVF5-1]
DR   Ensembl; ENST00000529824; ENSP00000433348; ENSG00000146426. [Q8IVF5-2]
DR   GeneID; 26230; -.
DR   KEGG; hsa:26230; -.
DR   UCSC; uc003qqb.3; human. [Q8IVF5-1]
DR   CTD; 26230; -.
DR   DisGeNET; 26230; -.
DR   GeneCards; TIAM2; -.
DR   H-InvDB; HIX0122219; -.
DR   HGNC; HGNC:11806; TIAM2.
DR   HPA; HPA011134; -.
DR   HPA; HPA013903; -.
DR   MIM; 604709; gene.
DR   neXtProt; NX_Q8IVF5; -.
DR   OpenTargets; ENSG00000146426; -.
DR   PharmGKB; PA36515; -.
DR   eggNOG; ENOG410ITS1; Eukaryota.
DR   eggNOG; ENOG410XPCM; LUCA.
DR   GeneTree; ENSGT00760000118925; -.
DR   HOVERGEN; HBG059279; -.
DR   InParanoid; Q8IVF5; -.
DR   KO; K16847; -.
DR   OMA; FNTLETP; -.
DR   OrthoDB; EOG091G00C8; -.
DR   PhylomeDB; Q8IVF5; -.
DR   TreeFam; TF319686; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   ChiTaRS; TIAM2; human.
DR   GenomeRNAi; 26230; -.
DR   PRO; PR:Q8IVF5; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000146426; -.
DR   CleanEx; HS_TIAM2; -.
DR   ExpressionAtlas; Q8IVF5; baseline and differential.
DR   Genevisible; Q8IVF5; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:Ensembl.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0005057; F:signal transducer activity, downstream of receptor; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IEA:InterPro.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   Gene3D; 2.30.29.30; -; 2.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR003116; RBD_dom.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF50729; SSF50729; 2.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50898; RBD; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell projection; Coiled coil; Complete proteome;
KW   Cytoplasm; Guanine-nucleotide releasing factor; Lipoprotein;
KW   Myristate; Phosphoprotein; Polymorphism; Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000255}.
FT   CHAIN         2   1701       T-lymphoma invasion and metastasis-
FT                                inducing protein 2.
FT                                /FTId=PRO_0000317467.
FT   DOMAIN      506    620       PH 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      810    881       RBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00262}.
FT   DOMAIN      890    976       PDZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00143}.
FT   DOMAIN     1099   1293       DH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00062}.
FT   DOMAIN     1347   1478       PH 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   COILED      628    695       {ECO:0000255}.
FT   MOD_RES    1583   1583       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q6ZPF3}.
FT   MOD_RES    1648   1648       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q6ZPF3}.
FT   LIPID         2      2       N-myristoyl glycine. {ECO:0000255}.
FT   VAR_SEQ       1   1075       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10512681,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030971.
FT   VAR_SEQ       1    688       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_030972.
FT   VAR_SEQ     787    787       Q -> QIFDSSGSHGFSGTQLPQNSSNSSE (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:10512681}.
FT                                /FTId=VSP_030974.
FT   VAR_SEQ    1317   1317       E -> EQPEWSSEVMDVLDPRGKLTKGTLEEPRTL (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_030975.
FT   VARIANT     332    332       R -> H (in dbSNP:rs931312).
FT                                /FTId=VAR_051994.
FT   VARIANT     913    913       R -> H (in dbSNP:rs7770537).
FT                                /FTId=VAR_051995.
FT   VARIANT    1089   1089       S -> P (in dbSNP:rs4259257).
FT                                {ECO:0000269|PubMed:10512681,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_051996.
FT   VARIANT    1101   1101       R -> C (in dbSNP:rs11751128).
FT                                /FTId=VAR_038534.
FT   VARIANT    1572   1572       D -> E (in dbSNP:rs1571767).
FT                                /FTId=VAR_038535.
FT   CONFLICT    506    506       V -> A (in Ref. 7; BAC86170).
FT                                {ECO:0000305}.
FT   CONFLICT    633    633       L -> P (in Ref. 1; AAF05900).
FT                                {ECO:0000305}.
FT   CONFLICT    722    722       L -> P (in Ref. 1; AAF05900).
FT                                {ECO:0000305}.
FT   CONFLICT    807    807       A -> T (in Ref. 1; AAF05900).
FT                                {ECO:0000305}.
FT   CONFLICT   1066   1066       R -> K (in Ref. 7; BAC86170).
FT                                {ECO:0000305}.
FT   CONFLICT   1092   1092       R -> G (in Ref. 6; AAH66979).
FT                                {ECO:0000305}.
FT   CONFLICT   1154   1154       Q -> R (in Ref. 6; AAH66979).
FT                                {ECO:0000305}.
FT   CONFLICT   1186   1186       S -> P (in Ref. 7; BAC86170).
FT                                {ECO:0000305}.
FT   CONFLICT   1306   1306       Q -> R (in Ref. 7; BAC86170).
FT                                {ECO:0000305}.
FT   CONFLICT   1365   1365       E -> K (in Ref. 7; BAC86170).
FT                                {ECO:0000305}.
FT   CONFLICT   1376   1376       N -> Y (in Ref. 6; AAH66979).
FT                                {ECO:0000305}.
FT   CONFLICT   1451   1451       R -> S (in Ref. 6; AAH66979).
FT                                {ECO:0000305}.
FT   CONFLICT   1482   1482       R -> G (in Ref. 6; AAH66979).
FT                                {ECO:0000305}.
FT   CONFLICT   1519   1519       D -> Y (in Ref. 7; BAC86170).
FT                                {ECO:0000305}.
FT   CONFLICT   1639   1639       A -> T (in Ref. 7; BAC86170).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1701 AA;  190103 MW;  C2C9C9B1782B7823 CRC64;
     MGNSDSQYTL QGSKNHSNTI TGAKQIPCSL KIRGIHAKEE KSLHGWGHGS NGAGYKSRSL
     ARSCLSHFKS NQPYASRLGG PTCKVSRGVA YSTHRTNAPG KDFQGISAAF STENGFHSVG
     HELADNHITS RDCNGHLLNC YGRNESIAST PPGEDRKSPR VLIKTLGKLD GCLRVEFHNG
     GNPSKVPAED CSEPVQLLRY SPTLASETSP VPEARRGSSA DSLPSHRPSP TDSRLRSSKG
     SSLSSESSWY DSPWGNAGEL SEAEGSFLAP GMPDPSLHAS FPPGDAKKPF NQSSSLSSLR
     ELYKDANLGS LSPSGIRLSD EYMGTHASLS NRVSFASDID VPSRVAHGDP IQYSSFTLPC
     RKPKAFVEDT AKKDSLKARM RRISDWTGSL SRKKRKLQEP RSKEGSDYFD SRSDGLNTDV
     QGSSQASAFL WSGGSTQILS QRSESTHAIG SDPLRQNIYE NFMRELEMSR TNTENIETST
     ETAESSSESL SSLEQLDLLF EKEQGVVRKA GWLFFKPLVT VQKERKLELV ARRKWKQYWV
     TLKGCTLLFY ETYGKNSMDQ SSAPRCALFA EDSIVQSVPE HPKKENVFCL SNSFGDVYLF
     QATSQTDLEN WVTAVHSACA SLFAKKHGKE DTLRLLKNQT KNLLQKIDMD SKMKKMAELQ
     LSVVSDPKNR KAIENQIQQW EQNLEKFHMD LFRMRCYLAS LQGGELPNPK SLLAAASRPS
     KLALGRLGIL SVSSFHALVC SRDDSALRKR TLSLTQRGRN KKGIFSSLKG LDTLARKGKE
     KRPSITQVDE LLHIYGSTVD GVPRDNAWEI QTYVHFQDNH GVTVGIKPEH RVEDILTLAC
     KMRQLEPSHY GLQLRKLVDD NVEYCIPAPY EYMQQQVYDE IEVFPLNVYD VQLTKTGSVC
     DFGFAVTAQV DERQHLSRIF ISDVLPDGLA YGEGLRKGNE IMTLNGEAVS DLDLKQMEAL
     FSEKSVGLTL IARPPDTKAT LCTSWSDSDL FSRDQKSLLP PPNQSQLLEE FLDNFKKNTA
     NDFSNVPDIT TGLKRSQTDG TLDQVSHREK MEQTFRSAEQ ITALCRSFND SQANGMEGPR
     ENQDPPPRSL ARHLSDADRL RKVIQELVDT EKSYVKDLSC LFELYLEPLQ NETFLTQDEM
     ESLFGSLPEM LEFQKVFLET LEDGISASSD FNTLETPSQF RKLLFSLGGS FLYYADHFKL
     YSGFCANHIK VQKVLERAKT DKAFKAFLDA RNPTKQHSST LESYLIKPVQ RVLKYPLLLK
     ELVSLTDQES EEHYHLTEAL KAMEKVASHI NEMQKIYEDY GTVFDQLVAE QSGTEKEVTE
     LSMGELLMHS TVSWLNPFLS LGKARKDLEL TVFVFKRAVI LVYKENCKLK KKLPSNSRPA
     HNSTDLDPFK FRWLIPISAL QVRLGNPAGT ENNSIWELIH TKSEIEGRPE TIFQLCCSDS
     ESKTNIVKVI RSILRENFRR HIKCELPLEK TCKDRLVPLK NRVPVSAKLA SSRSLKVLKN
     SSSNEWTGET GKGTLLDSDE GSLSSGTQSS GCPTAEGRQD SKSTSPGKYP HPGLADFADN
     LIKESDILSD EDDDHRQTVK QGSPTKDIEI QFQRLRISED PDVHPEAEQQ PGPESGEGQK
     GGEQPKLVRG HFCPIKRKAN STKRDRGTLL KAQIRHQSLD SQSENATIDL NSVLEREFSV
     QSLTSVVSEE CFYETESHGK S
//
